Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them-Reference-Cited by-同舟云学术

Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them

Published:2018-06-18 Issue:9 Volume:14 Page:2303-2309
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wantuch Paeton L.¹,Avci Fikri Y.¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Center for Molecular Medicine and Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2018.1470726

Reference46 articles.

1. A Brief History of the Pneumococcus in Biomedical Research: A Panoply of Scientific Discovery

2. The Significance of Pneumococcal Types

3. The immunological mechanisms that control pneumococcal carriage

4. Pneumococcal Capsules and Their Types: Past, Present, and Future

5. The role of vaccination in preventing pneumococcal disease in adults

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, spatial distribution and determinants of complete childhood pneumococcal conjugate vaccination in Ethiopia: spatial and multilevel analyses;BMC Public Health;2024-09-06

2. Evaluating patient immunocompetence through antibody response to pneumococcal polysaccharide vaccine using a newly developed 23 serotype multiplexed assay;Clinical Immunology;2024-08

3. Impact of Demographic Developments and PCV13 Vaccination on the Future Burden of Pneumococcal Diseases in Germany—An Integrated Probabilistic Differential Equation Approach;Mathematics;2024-03-08

4. Time-resolved RNA-seq analysis to unravel the in vivo competence induction by Streptococcus pneumoniae during pneumonia-derived sepsis;Microbiology Spectrum;2024-03-05

5. Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016–21;International Journal of Antimicrobial Agents;2024-02